Pharmacy
-
Opioid Analgesic Treatment
-
Effective January 1st 2019, please submit requests for controlled substances using the new Uniform Prescription Drug Prior Authorization Form. Please review the pharmacy authorization guidelines to ensure you have submitted all guideline requirements.
Louisiana Uniform Prescription Drug Prior Authorization Form
The Louisiana Department of Health Resources
The Department would like to share our new “Opioid” web page. There are many great resources posted here:
http://ldh.la.gov/index.cfm/subhome/54
April 2017 Provider Update includes Morphine Equivalent Dose information:
http://www.lamedicaid.com/Providerupdate/provider_update_04_17.pdf
-
LDH Pharmacy Staff Communications
-
The Louisiana Department of Health would like to share their new “Opioid” web page. There are many great resources posted here
Louisiana Medicaid Pharmacy Adult Vaccine Coverage Policy Update - Effective September 15, 2020
Louisiana Medicaid Pharmacy Point of Sale Clinical Authorization for Select Drugs - August 3, 2020
Louisiana Medicaid Pharmacy Point of Sale (POS) Edits for Lumateperone (Caplyta) - August 3, 2020
Louisiana Medicaid Pharmacy Point of Sale (POS) Quantity Limits - August 03, 2020
August Provider Update Newsletter
Delayed Long-term Care and Pharmacy Provider Payments Memo
FFS Pharmacy Adult Vaccine Billing
FFS and MCO Pharmacy Adult Vaccine Coverage
Pharmacy Facts 05/18/20 (Revised)
Louisiana Fee for Service (FFS) Medicaid Updated 340B Billing Policy - Effective August 5, 2019
Don’t forget about the Naloxone Standing Order:
http://ldh.la.gov/assets/docs/BehavioralHealth/Opioids/Naloxonestandingorder.pdf
April 2017 Provider Update includes Morphine Equivalent Dose information:
http://www.lamedicaid.com/Providerupdate/provider_update_04_17.pdf
Formulary drug list
The formulary is a list of drugs chosen by Louisiana Department of Health's Pharmacy P & T Committee and administered by Aetna Better Health of Louisiana. Drugs are listed as preferred and non-preferred. All non-preferred drugs are required to follow the prior authorization process.
There is a subset of drugs not listed on the Louisiana Medicaid Single PDL which may be available for coverage. These drugs typically do not require a prior authorization. Generic substitution is mandated by the state unless a drug is on the preferred drug list as a Brand Name product. Clinical edits, such as quantity limits and age restrictions, may apply to some drug categories.
Members must fill their prescriptions at an Aetna Better Health of Louisiana network pharmacy and follow other plan rules.
Please review the formulary for any restrictions or recommendations regarding prescription drugs before prescribing a medication to an Aetna Better Health of Louisiana patient.
Louisiana Medicaid Single PDL (Fee For Service and Managed Care Organizations)
-
Over-the-counter drugs
-
Aetna Better Health also covers certain over-the-counter drugs (OTC). Some drugs are covered on the state’s Single Preferred Drug List (SPDL). SPDL OTC drugs require a prescription from a provider. The links have been provided below for your review.
Louisiana Medicaid Single PDL (Fee For Service and Managed Care Organizations)
Enrollees have an additional OTC benefit. Enrollees can access a catalog of available OTC drugs. You can check with Enrollee Services at 1-855-242-0802, TTY 711, for more information, how to access the catalog and assistance with orders*.
-
Pharmacy authorization guidelines
-
Effective May 1st, 2019, Aetna Better Health® of Louisiana adheres to the Healthy LA PDL clinical criteria to make decisions when you send in a request for a drug on the formulary/PDL that needs a review prior to being dispensed.
To access clinical criteria, click here to be taken to the Healthy LA Pharmacy clinical criteria.
Additional criteria found below will also apply as of May 1st, 2019.
Compounds (effective 12.02.2019)
Diabetic Testing Supplies (effective 01.01.2021)
Quantity Level Limits (effective 08.18.2020)
-
Hep C Subscription Model
-
Hep C Policy Criteria (Authorized Generic(AG) Epclusa Preferred)
-
Pharmacy prior authorization forms
-
To quickly find a prior authorization form, click CTRL F on your keyboard and type in the form name.
Louisiana Uniform Prescription Drug Prior Authorization Form
Hepatitis C Patient Treatment Agreement
Spinraza (Medical Benefit only through ABHLA)
-
Electronic Prior Authorization (ePA)
-
We are committed to making sure our providers receive the best possible information, and the latest technology and tools available.
We have partnered with CoverMyMeds® and SureScripts to provide you a new way to request a pharmacy prior authorization through the implementation of Electronic Prior Authorization (ePA) program.
With Electronic Prior Authorization (ePA), you can look forward to:
- Time saving
- Decreasing paperwork, phone calls and faxes for requests for prior authorization
- Quicker Determinations
- Reduces average wait times, resolution often within minutes
- Accommodating & Secure
- HIPAA compliant via electronically submitted requests
No cost required! Let us help get you started!
Getting started is easy. Choose ways to enroll:
- Visit the CoverMyMeds® website
- Call CoverMyMeds® toll-free at 866-452-5017
- Visit the SureScripts website
- Call SureScripts toll-free at 866-797-3239
Billing Information:
BIN: 610591
PCN: ADV
Group: RX8834
-
Prescription Monitoring Program
-
The Prescription Monitoring Program (PMP) is accessed by utilizing the Louisiana Board of Pharmacy.
-
Quantity Limits
-
Certain drugs on the formulary have quantity limits (QLLs). The QLLs are established based on FDA-approved dosing levels and nationally- established, recognized guidelines pertaining to the treatment and management of the condition being treated.
To request an override for the quantity limit, please fax the correct pharmacy Prior Authorization request form to 1-844-699-2889. You can include any medical records that will support your request.
-
Pharmacy & Therapeutics Committee
-
Pharmacy & Therapeutics Committee Meetings
10000 Perkins Rowe, Suite 500, Baton Rouge, LA. 70810, 5:30 – 7PM. ABHLA complies with Open Meetings Laws.
Dates: 2020 P&T Committee Meeting (Tentative)
- 1st Biannual Meeting, Tuesday, June 23, 2020
- 2nd Biannual Meeting, Tuesday, December 8, 2020 (cancelled) new date TBA.
Due to limited seating, please RSVP Vanessa Smith at smithv9@aetna.com.
*Go to the central elevator and come to the 5th floor. If the door is not open, please call (225) 315-9561 to gain access.*
Meeting agendas
If you have any questions contact:
Vanessa N. Smith, DPh
Director of Pharmacy
(504) 667-4544 Office
SmithV9@ aetna.com
Pharmacy & Therapeutics Committee Guidelines
-
Diabetic Supplies
-
DUR Quarterly Education
-
Q3 DUR Education - Fraud, Waste, Abuse: Footbaths
Q2 DUR Education - CBD Oil and Drug Interactions
Q1 DUR Education - Antidepressants and Breastfeeding